Sudarshan Pharma Industries LtdBSE: SUDARSHAN

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

· Issued by Sudarshan Pharma Industries Ltd via BSE India

Filed with BSE · · 5 pages · English

On 6ix: 6ix.com/news/revised-disclosures-under-reg-311-and-312-of-sebi-sast-regulations-2011-16

Release

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 09, 2026 for Hemal V Mehta HUF, Mrs. Devangi Hemal Mehta, Sachin V Mehta HUF and Mrs. Namrata Sachin Mehta

Sudarshan Pharma Industries Ltd on 6ix

Earlier from Sudarshan Pharma Industries

Later from Sudarshan Pharma Industries

All Sudarshan Pharma Industries news releases